Why is Rocket Lab stock surging today?

Rocket Lab shares rose nearly 7.7% to $69.53 after investors absorbed dilution from its completed $1.94B at-the-market offering, which finalizes financing for its pending $8B acquisition of Iridium Communications. Cantor Fitzgerald reiterated an Overweight rating and $122 price target, while reported SpaceX IPO plans supported space-sector sentiment. Rocket Lab also highlighted improving launch economics, with Q2 2026 average revenue per launch up to $9.1M from $7.9M a year earlier, alongside a record $2.36B backlog.

Analysis

The financing completion removes a near-term technical seller, but it does not resolve the more important valuation question: whether the acquired cash flows can justify the incremental equity base and transaction-related leverage. RKLB now shifts from a pure launch-and-space-systems multiple toward a capital-allocation story, where execution on integration, cross-selling, and any refinancing needs will drive the multiple over the next 6-18 months. The relevant KPI is not launch cadence alone but consolidated EBITDA-to-interest coverage and free-cash-flow conversion after satellite-network capex.

IRDM holders face a different setup: deal-spread behavior should increasingly dominate fundamentals until closing. Any widening in the implied spread would likely signal financing, regulatory, or closing-risk concerns rather than a deterioration in its operating business; this makes IRDM a useful real-time hedge indicator for RKLB acquisition risk. A SpaceX listing narrative can support sector beta over days to weeks, but it may ultimately expose RKLB to direct public-market benchmarking on growth, margins, launch reliability, and addressable market—potentially limiting rather than expanding the scarcity premium once listing terms become known.

Consensus appears to be treating the reversal as proof that dilution is fully digested. That is premature without the offering's average issuance price, final diluted share count, acquisition financing mix, and pro forma guidance. A sustained rerating requires management to demonstrate that acquired recurring connectivity revenue lowers RKLB's cash-burn and revenue-volatility profile; absent that, momentum buyers may fade on the first post-close earnings call or any Neutron schedule/capex revision.

Key Decisions for Investors

• Do not chase the opening rebound in RKLB; initiate only on a pullback or after disclosure of pro forma share count and leverage. Size as a 3-6 month tactical long only if the acquisition model shows accretion to 2027 EBITDA/FCF, with a stop on a material increase in expected post-close cash burn or a launch/schedule miss.
• Monitor the IRDM deal spread daily through closing. A persistent widening versus the stated consideration is an actionable warning to reduce RKLB exposure; a narrowing spread combined with confirmed regulatory clearance supports adding to RKLB ahead of close.
• For investors already long RKLB, use a defined-risk collar over the next earnings and deal-close window: sell upside calls into the SpaceX-IPO sympathy bid and buy downside puts below the post-financing low. This protects against multiple compression if the market focuses on dilution and integration costs rather than sector beta.
• Avoid treating SPCX as a tradable public comparable until verified listing details, valuation, float, and lockup terms are available. The key watch item is whether an eventual IPO prices at a premium that validates public space-infrastructure multiples or at a discount that resets them.